A Phase I Study of Euthare-155008(ETH-155008) in AML and NHL Patients

NCT05758610 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

NHL, Adult
AML, Adult Recurrent

Interventions

DRUG: ETH-155008

Sponsor

Shengke Pharmaceuticals (Jiangsu) Limited, China